Peptides DB
Research-centric peptide and protocol reference hub
Study 38 of 45VIP (Vasoactive Intestinal Polypeptide) literatureEndocrinology, diabetes & metabolism case reports · Case reportHigh-impact journal2026

Composite pheochromocytoma-ganglioneuroma secreting vasoactive intestinal peptide.

This case highlights a rare occurrence of VIP secretion in a composite pheochromocytoma-ganglioneuroma, with normalization of VIP levels following surgical intervention.

Read at Endocrinology, diabetes & metabolism case reportsAdd to compare

Where it sits

this study against the rest of the vip (vasoactive intestinal polypeptide) corpus
9
Preclinical
29
Observational · this one
1
Open-label
2
Randomised
4
Reviews

Summary and findings

An 80-year-old female with a 10-year history of diarrhea and chronic hyponatremia was found to have a 6.8-centimeter right adrenal mass. Elevated levels of vasoactive intestinal peptide (VIP) were noted, and surgical resection confirmed a composite pheochromocytoma-ganglioneuroma. Postoperatively, plasma levels of VIP and normetanephrines normalized, along with resolution of diarrhea and other symptoms.

How much of this paper we could read: full text read (0.80). We had a clear abstract, so the summary below closely tracks the paper. What this means →
Maximal SUV of 14.4.2026

Abstract

The authors’ words, as Endocrinology, diabetes & metabolism case reports supplied them

Summary An 80-year-old female patient presented with a 10-year history of progressively worsening diarrhea and chronic hyponatremia. An abdominal computed tomography (CT) revealed a 6.8-centimeter right adrenal mass. A Ga-68 DOTATATE positron emission tomography (PET)/CT scan subsequently demonstrated a significant expression of somatostatin receptors on the tumoral shell (maximal SUV of 14.4), associated with a hypometabolic central portion. Endocrine investigation indicated elevated levels of both urinary and plasmatic normetanephrines. Given the watery diarrhea, VIP levels were measured, which were markedly elevated. Surgical resection confirmed a composite pheochromocytoma-ganglioneuroma with VIP immunoreactivity in both tumor components. In the postoperative period, the plasma levels of VIP and normetanephrines returned to normal with resolution of diarrhea, hyponatremia, and hypertension. This case illustrates a rare instance of composite pheochromocytoma-ganglioneuroma with co-secretion of catecholamines and VIP, with evidence of VIP production in both tumor components. The finding of VIP secretion in the pheochromocytoma and the ganglioneuroma suggests that both tumors might originate from the same cell of neural crest origin. Learning points

Background

Not reported in abstract.

Methods

Not reported in abstract.

Results

Not reported in abstract.

Interpretation

Not reported in abstract.

Limitations

Not reported in abstract.

Elsewhere in the VIP (Vasoactive Intestinal Polypeptide) corpus

CLongitudinal Imaging in a Mouse Model of Focal Cortical Dysplasia Reveals Lesion Expansion and Loss of Pre-Discharge Neuronal Recruitmentbiorxiv-preprint · 2026 · Not reported in abstract.AnimalCCortex-wide imaging in naturally behaving mice with 1-gram wireless mesoscopes.Nature · 2026AnimalCCalcium-Binding Protein Expression Cannot Serve as a General Classifier for GABAergic Neurons in the Macaque Cortex.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2026 · up to 50% of neurons expressing CBPs are likely not GABAergicAnimalCATR-FTIR spectral fingerprinting and Chemometric classification of Labisia pumila varieties with exploratory screening of herbal products.Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy · 2026 · R²Y = 0.894, Q² = 0.894 for the final PLS-DA model.In vitroBIon Channels and Morphology Drive Widespread Resonance in Human Cortical Interneuronsbiorxiv-preprint · 2026 · Not reported in abstract.HumanDClinical update: Assessment and management of Helicobacter pylori infection.BMJ (Clinical research ed.) · 2026review